How cryolipolysis works
Cryolipolysis exploits a simple observation: fat cells are more vulnerable to cold than the surrounding skin and other tissues. A device draws a fold of tissue into an applicator and cools it to a controlled low temperature, held long enough to injure the fat cells without damaging the skin, nerves or vessels.
The injured fat cells then undergo a gradual process of programmed cell death and are cleared by the body over the following weeks and months. This is why results are not immediate. The fat cells are damaged during the session, but the visible reduction develops slowly as they are removed, typically becoming apparent from around six weeks and settling by three months.
The session itself is straightforward and undramatic. An applicator draws the fold of tissue in and cools it for a set period, often around half an hour to an hour per area, during which the treated tissue goes numb. There is an intense cold and a pulling sensation at the start that most patients tolerate without difficulty, and they can typically read or work through it. That undemanding experience is a large part of the treatment's popularity, but it should not be mistaken for the treatment being trivial in its effect, which is permanent.
Crucially, cryolipolysis reduces the number of fat cells in the treated area rather than shrinking them. That is the same mechanism whether the target is the abdomen, flanks, thighs or under the chin.
The distinction between reducing cell number and shrinking cells is more than a technicality. Diet and exercise shrink existing fat cells without removing them, which is why lost weight can return to the same places. Cryolipolysis removes a proportion of the cells outright, so the treated pocket has a lower capacity to store fat in future. That is the basis of the claim that results are lasting, but it comes with an important qualification: the remaining cells in the area can still enlarge with significant weight gain, so the outcome is durable only against a background of broadly stable weight.
What reduction to realistically expect
The published evidence, including ultrasound and caliper measurements, supports a reduction in the thickness of the treated fat layer of roughly 20 to 25 per cent per cycle in appropriate candidates. That figure is often misread. It is a reduction in the fat layer at that spot, not a reduction in body weight or clothing sizes across the board.
A 20 to 25 per cent reduction in a discrete fat layer is a real change in contour and a very small change on the scales. Confusing the two is the source of most disappointment.
Some patients need more than one cycle to a given area to reach the result they want, spaced a couple of months apart. And because the treatment reduces a fixed pocket of fat, remaining fat cells can still expand if a patient gains weight, so the result depends on stable weight to be maintained.
Who it suits and who it does not
The ideal candidate is close to their target weight with discrete, pinchable pockets of fat that resist diet and exercise. Classic examples are the lower abdomen, flanks and the fat under the chin. For these patients cryolipolysis offers a non-surgical way to refine contour with no incisions and little downtime.
| Candidate profile | Suitability |
|---|---|
| Near target weight, discrete pinchable bulge | Good |
| Localised diet-resistant fat, stable weight | Good |
| Seeking overall weight loss | Poor, wrong treatment |
| Loose skin as the main concern | Poor, skin laxity is a different problem |
| Visceral fat around the organs | Not treatable, cryolipolysis reaches only subcutaneous fat |
The important negative is that cryolipolysis is not a weight-loss treatment and does nothing for visceral fat, the deep fat around the organs that a fold cannot pull into an applicator. A patient whose real goal is weight loss, or whose main issue is loose skin rather than fat, is being mismatched to the treatment.
Skin quality is the quieter selection factor. Because the treatment reduces the volume of fat beneath the skin, a patient with poor skin elasticity may find that reducing the underlying fat leaves the overlying skin looser rather than smoother. In the right candidate, with reasonable skin tone, the skin retracts and the contour improves. In the wrong one, the result can be a hollow that highlights existing laxity. A good consultation assesses the skin as carefully as the fat, and a clinic that only pinches the bulge without considering what sits over it is assessing half the problem.
Paradoxical adipose hyperplasia
The complication that most deserves discussion is paradoxical adipose hyperplasia, or PAH. Instead of shrinking, the treated area develops a firm, enlarged mass of fat, often described as taking the shape of the applicator. It is the opposite of the intended result.
PAH is uncommon, but it is real and recognised in the literature. It appears to be more common in men and does not resolve on its own; correcting it generally requires liposuction or surgery. The mechanism is not fully understood. The practical points for a patient are that it is a documented risk, that it should be disclosed at consultation, and that a clinic which has never mentioned it is either unaware of it or choosing not to say.
The existence of PAH is a reminder that cryolipolysis, despite its non-surgical, low-downtime image, is a treatment that permanently alters tissue and carries genuine, if uncommon, risks.
Other risks and downtime
Beyond PAH, cryolipolysis is generally well tolerated. The common effects are temporary: redness, swelling, bruising, firmness and numbness in the treated area, which can persist for a few weeks. A tugging sensation during the session as tissue is drawn into the applicator is normal, and some patients experience a delayed nerve pain that settles over time.
Downtime is minimal, and most people return to normal activity immediately. That low-downtime profile is part of the appeal, but it should not be mistaken for a treatment without consequences, given the permanence of the fat-cell reduction and the PAH risk.
Device quality matters more than the low-downtime image suggests. The cryolipolysis market includes both established systems with published data and a long tail of cheaper devices sold on price. A lower-cost machine may deliver less controlled cooling, which affects both effectiveness and the margin of safety against injuring the skin. Very low pricing for a cycle is often a signal that the underlying device, or the experience of the operator selecting candidates, is not what a patient is assuming. As ever in this sector, the cheapest quote is rarely the one to optimise for.
Cost and choosing a clinic
UK pricing in 2026 runs from roughly £400 to £900 per area per cycle, with many patients needing more than one cycle or more than one area, so total costs add up. Our guide to what aesthetic treatments cost in the UK in 2026 places this alongside other body treatments. Very low pricing may indicate an older or less capable device, or an operator without the experience to select candidates well.
Candidate selection is where a good clinic earns its fee. Turning away patients who want weight loss, or whose real issue is skin laxity, is a sign of a clinic doing its job. Verifying the practitioner and setting, as our explainer on what an aesthetic clinic actually means in UK law describes, is sensible, and the MHRA regulates the devices themselves.
